Adverse effect of hemostatic drug, subsequent encounter

This code signifies a patient experiencing an unintended and undesirable reaction to a medication administered to control bleeding, such as an antifibrinolytic or procoagulant. The adverse effect is not due to an overdose or poisoning, but rather a normal therapeutic dose. This specific code is used when the patient is receiving follow-up care for the adverse effect after the initial treatment.

Apply this code when a patient presents for ongoing management or evaluation of a previously identified adverse reaction to a hemostatic agent. Examples include follow-up appointments for persistent rash, abnormal lab values, or organ dysfunction attributed to the hemostatic drug, after the initial acute phase of treatment.

• Always assign an additional code for the specific manifestation of the adverse effect (e.g., rash, liver damage).
• Ensure the documentation clearly indicates the adverse effect is from a hemostatic drug and not another class of medication.
• The "D" seventh character indicates subsequent encounter, meaning the patient is receiving routine care during the healing or recovery phase.